Science ❯ Biotechnology

Pharmaceuticals

Drug Development Clinical Trials Vaccine Development Drug Discovery Clinical Research Drug Delivery Systems Antibiotics Antibody Development Antibiotic Development Weight Loss Drugs

AI‑Designed Miniproteins Can Switch GPCRs On or Off, Study Reports

A Nature paper shows a pipeline that pairs computational design with a native‑cell high‑throughput screen to create preclinical GPCR drug candidates.

NervGen Prices $60 Million Public Offering of Shares and Warrants

Isomorphic Labs Raises $2.1 Billion to Scale AI Drug Design

Roche to Acquire PathAI for $750 Million Upfront Plus Up to $300 Million in Milestones

Regeneron and Telix Form 50/50 Partnership to Develop Targeted Radiopharmaceuticals

Dog Longevity Pill Advances After FDA Safety Check

Mexico Clears Takeda’s Qdenga Dengue Vaccine for Private-Sector Sale

MIT Tests Biodegradable Pill That Signals When It’s Swallowed

Spanish-Led Spinal Cord Implant Project Seeks Investors to Advance Toward Human Trials

MoonLake Immunotherapeutics Investors Face Lead‑Plaintiff Deadline in Securities Fraud Suits

Janux Plunges on Mixed Phase 1 Prostate Cancer Data for JANX007

Polymer Lets Insulin Cross Skin in Animals, Matching Injections in Early Tests

Centessa Prices $250 Million ADS Offering at $21.50 as Shares Hit Record High

Sheffield's M102 Slows Motor Neurone Disease in Mice

Biovac Opens Cape Town Product Development Lab to Advance Africa’s Vaccine Capacity

Biogen Licenses Vanqua’s Preclinical C5aR1 Drug in Deal Worth Up to $1.06 Billion

Russia’s Flu Season Starts Slowly as Hospitalizations Tick Up

Santander Warns of 286% Surge in Weight-Loss Jab Scams Since January

AI-Guided Antibiotic Enterololin Targets Crohn’s-Linked Bacteria

CSL Secures VarmX Acquisition Option, Funding Phase 3 of Factor Xa Reversal Drug